Table 4.
Sensitive analysis: average treatment effect for Region Skåne and Stockholm using comorbidities registered in the SRR and while controlling for the Charlson comorbidity index.
| Using Registered Comorbidities Coef. (95% CI) | Charlson Comorbidity Index Coef. (95% CI) | |
|---|---|---|
| For patients on the waitlist (n = 1129) | ||
| ATE | ||
| KTx vs. dialysis | 12.0 (6.8–17.3) | 11.9 (6.8–17.1) |
| POM | ||
| KTx | 25.0 (20.9–29.0) | 24.7 (20.7–28.7) |
| Dialysis | 12.9 (9.5–16.4) | 12.8 (9.4–16.2) |
| For all RRT patients (n = 4519) | ||
| ATE | ||
| KTx vs. dialysis | 12.4 (9.4–15.4) | 12.3 (9.0–15.5) |
| POM | ||
| KTx | 17.5 (14.5–20.5) | 17.4 (14.2–20.6) |
| Dialysis | 5.2 (4.9–5.4) | 5.2 (4.9–5.5) |
CI = confidence interval; KTx = kidney transplantation; ATE = average treatment effect; POM = potential outcome mean.